CT Scanner

Published Jun 25, 2026Live

Performance since launch

Total return
Max drawdown
Frequency
Risk level
Low

Backtest volatility

About this strategy

Weekly-rebalanced basket of pharma and biotech stocks weighted by recent Phase 3 clinical-trial activity.

How it works

  1. Agent triggers

    Triggered weekly on Monday at market open. A fresh run begins to select stocks based on recent Phase 3 clinical-trial activity.

  2. Computes its signals

    It ranks stocks in the biotech and pharma universe based on their clinical-trial milestones, focusing on distinct recent activities.

  3. Sets the target portfolio

    The target portfolio consists of a weekly rotating basket of stocks, with a maximum turnover allowing for significant updates as new data emerges.

  4. Executes orders

    Your account trades toward the target, sells before buys, inside the platform's risk rails: stop-loss and daily loss limits you control.

Ask this agent

. Preview chat needs an account.

Answers describe the strategy’s rules, not investment advice.

Backtests

* Backtest figures are simulated based on historical market data. Past performance is not indicative of future results.